相关实验视频
Updated: May 9, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.4K
血动脉生成指数与痴呆症之间的关联:一项纵向观察性研究
1Department of Neurosurgery, West China Hospital, Sichuan University / West China School of Nursing, Sichuan University, Chengdu, China.
Journal of Alzheimer's disease : JAD
|May 5, 2025
概括
高血动脉原体指数 (AIP) 与痴呆症风险增加有关,特别是在糖尿病患者中. 这种脂质代谢生物标志物可以作为早期痴呆症指标.
科学领域:
- 心血管健康 心血管健康
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 血无氧原体指数 (AIP) 是一种新的脂质代谢生物标志物.
- AIP与痴呆风险之间的关联尚未得到充分证实.
- 了解这种联系对于早期痴呆症检测和预防策略至关重要.
研究的目的:
- 为了调查AIP和事件痴呆症之间的关联.
- 为了检查不同血糖状况之间的这种关联.
- 确定AIP作为痴呆症的潜在早期指标.
主要方法:
- 利用了来自中国健康与退休长度研究的数据 (年龄≥45岁的5195名成年人).
- 从2011-2012年到2018年对痴呆症发病率进行了跟踪.
- 使用甘油三和高密度胆固醇水平计算AIP,通过逻辑回归分析.
主要成果:
- 在基本模型中,较高的AIP与剂量依赖的痴呆风险增加有关.
- 在糖尿病患者中,高AIP和痴呆症之间的关联是显著的 (OR: 1.97).
- 在高AIP和血糖状况 (p=0.029) 之间发现了显著的相互作用.
结论:
- 高AIP与痴呆的风险增加有关.
- 这种联系在糖尿病患者中尤为明显.
- AIP可以作为痴呆症发展的早期预警信号.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.0K
相关概念视频
Dementia
64
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
64
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315